GlassScriptPhysician profile
Cheryl Iglesia
NPI 1770553919
$8,971.38
in general payments reported to CMS, 2019-2025
14 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.81 · 2020: $29.78 · 2021: $1,915 · 2022: $2,505 · 2023: $1,929 · 2024: $2,318 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,357 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Travel and Lodging: $621 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,356.55 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Travel and Lodging | $621.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $3,575.26 | 2021-2023 | |
| Axonics, INC. | $2,252.49 | 2021-2024 | Axonics |
| Intuitive Surgical, INC. | $1,098.73 | 2024 | |
| Caldera Medical, INC | $1,062.45 | 2021-2024 | Desara |
| Boston Scientific Corporation | $522.32 | 2021-2025 | Upsylon, Advantage System |
| Conmed Corporation | $168.88 | 2024 | Airseal |
| Coopersurgical, INC. | $115.75 | 2024 | Wallach Cryosurgical Equipment |
| Sumitomo Pharma America, INC. | $44.70 | 2024-2025 | Gemtesa, Myfembree |
| Olympus America INC. | $35.81 | 2019 | |
| Contura, INC. | $29.78 | 2020 | |
| Abbvie INC. | $25.39 | 2025 | |
| Renovia INC | $21.63 | 2021 | |
| Coloplast Corp | $18.19 | 2023 | Altis |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Iglesia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.